Virtual care tech firm lands $300m vote of confidence
BOSTON: The digital medicine solutions developer has received $300m in a Series D investment round, which will be used to help scale up its virtual care offerings.
Biofourmis, a health technology developer specializing in digital medicine and virtual care solutions, has landed $300m USD in a Series D investment round, with contributors including CVS Health. The company intends to use the investment funds (which brings its total raised to $445m USD) to grow its digital medicine, fund clinical trials to advance digital therapeutics (DTx), and expand its Care@Home virtual care platform.
